We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 22 results
  1. The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation

    Hepatocellular carcinoma (HCC) is an extraordinarily heterogeneous tumor, which holds high recurrence and metastasis rates. Liver cancer stem cells...

    **g Shi, Cao Guo, ... Junli Ma in Cell Death & Disease
    Article Open access 16 November 2022
  2. A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability

    Liver cancer stem cells (LCSCs) are recognized as key contributors to hepatocarcinogenesis, progression, and recurrence. Consequently, eradicating...

    Zhichun Zhang, Yuan Qiao, ... Lichao Sun in Cell Death Discovery
    Article Open access 23 September 2023
  3. MYH9 is crucial for stem cell-like properties in non-small cell lung cancer by activating mTOR signaling

    The fatality rate of non-small cell lung cancer (NSCLC) has been high due to the existence of cancer stem cells (CSCs). Non-muscle myosin heavy chain...

    Meng Chen, Li-**n Sun, ... Yu-Liang Ran in Cell Death Discovery
    Article Open access 11 October 2021
  4. S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity

    Background

    Lung cancer is one of the most frequently diagnosed cancers characterized by high mortality, metastatic potential, and recurrence....

    Melina Muñoz-Bernart, Nicolás Budnik, ... Carolina Perez-Castro in Biology Direct
    Article Open access 05 March 2023
  5. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside

    Lung cancer has been one of the leading causes of cancer-related death worldwide, and non-small-cell lung cancer (NSCLC) accounts for the majority of...

    Qin Hu, Huiyun Ma, ... Qun Xue in Cell Death Discovery
    Article Open access 13 August 2022
  6. LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy

    In hepatocellular carcinoma (HCC), immunotherapy is vital for advanced-stage patients. However, diverse individual responses and tumor heterogeneity...

    Haojun Wang, Quanwei Zhou, ... Wei Wang in Cell Death & Disease
    Article Open access 22 February 2024
  7. Interplay of autophagy and cancer stem cells in hepatocellular carcinoma

    Liver cancer is the sixth most common cancer and the fourth leading cause of cancer deaths in the world. The most common type of liver cancers is...

    Magdelyn Mei-Theng Wong, Hui-Yin Chan, ... Sin-Yeang Teow in Molecular Biology Reports
    Article 24 April 2021
  8. Advances in Liver Cancer Stem Cell Isolation and their Characterization

    Over the last decade research on cancer stem cells (CSC) significantly contributed to a better understanding of tumor biology. Given their similarity...

    Lu Liu, Jürgen Borlak in Stem Cell Reviews and Reports
    Article 11 January 2021
  9. Mechanism of cancer stemness maintenance in human liver cancer

    Primary liver cancer mainly includes the following four types: hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), hepatoblastoma (HB), and...

    Ning Liang, Tao Yang, ... **anli He in Cell Death & Disease
    Article Open access 21 April 2022
  10. hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

    The relationship between circular RNA (circRNA) and cancer stem cells (CSCs) is uncertain. We have investigated the combined influence of CSCs,...

    Changhui Li, Jiaqi Zhang, ... Xueyan Zhang in Cell Death & Disease
    Article Open access 25 August 2021
  11. CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer

    Lung cancer is one of the most common reasons for cancer-induced mortality across the globe, despite major advancements in the treatment strategies...

    Jeong-Yub Kim, Hee-** Kim, ... Myung-** Park in Cell Death & Disease
    Article Open access 07 January 2021
  12. A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer

    According to a paper released and submitted to WHO by IARC scientists, there would be 905,700 new cases of liver cancer diagnosed globally in 2020,...

    Leila Kalantari, Zahra Rostami Ghotbabadi, ... Nikoo Emtiazi in Cell Communication and Signaling
    Article Open access 09 November 2023
  13. MiR-153 reduces stem cell-like phenotype and tumor growth of lung adenocarcinoma by targeting Jagged1

    Background

    Cancer stem cells (CSCs) have been proposed to be responsible for tumor recurrence and chemo-resistance. Previous studies suggested that...

    Guoli Zhao, Yueying Zhang, ... Hengxiao Wang in Stem Cell Research & Therapy
    Article Open access 06 May 2020
  14. Oncogenic activation of EEF1A2 expression: a journey from a putative to an established oncogene

    Protein synthesis via translation is a central process involving several essential proteins called translation factors. Although traditionally...

    Saket Awadhesbhai Patel, Md. Khurshidul Hassan, Manjusha Dixit in Cellular & Molecular Biology Letters
    Article Open access 03 January 2024
  15. Ubiquitous protein lactylation in health and diseases

    For decades, lactate has been considered a byproduct of glycolysis. The lactate shuttle hypothesis shifted the lactate paradigm, demonstrating that...

    Junyong Wang, Ziyi Wang, ... Ya** Guo in Cellular & Molecular Biology Letters
    Article Open access 05 February 2024
  16. A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors

    Fenretinide is a synthetic retinoid characterized by anticancer activity in preclinical models and favorable toxicological profile, but also by a low...

    Isabella Orienti, Federica Francescangeli, ... Ann Zeuner in Cell Death & Disease
    Article Open access 23 July 2019
  17. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors

    Normal cells become cancer cells after a malignant transformation, but whether cancer cells can be reversed to normal status remains elusive. Here,...

    Zhuo Cheng, Zhiying He, ... ** Ding in Cell Research
    Article 18 December 2018
  18. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

    Tyrosine kinase inhibitors (TKIs) have shown strong activity against non-small-cell lung cancer (NSCLC) patients harboring activating epidermal...

    G Sette, V Salvati, ... A Eramo in Cell Death & Disease
    Article Open access 06 August 2015
  19. Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors

    Background

    Lung cancer is the leading cause of cancer-related deaths worldwide, and treatments for lung cancer have a high failure rate....

    Yuyi Wang, Ming Jiang, ... Feng Luo in Cell & Bioscience
    Article Open access 23 December 2015
  20. Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer

    Lung cancer is the most common cause of cancer-related mortality worldwide, urging the discovery of novel molecular targets and therapeutic...

    A Zeuner, F Francescangeli, ... R De Maria in Cell Death & Differentiation
    Article 18 July 2014
Did you find what you were looking for? Share feedback.